tm
Seeing Is Believing
tm
Seeing Is Believing
Calidi Biotherapeutics's activity chart (see below) currently has 2 price targets and 2 ratings on display.
Analysts average stock forecasts to be materialized ratio is 22.22% with an average time for these price targets to be met of 149.67 days.
Most recent stock forecast was given by AYDIN HUSEYNOV from LADENBURG on 27-Jun-2024. First documented stock forecast 09-Oct-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Jun-2024
$14400.01
$14398.93 (1333234.25%)
2 years 3 months 27 days ago
(27-Jun-2024)
0/1 (0%)
$14375.17 (57871.05%)
Buy Since 09-Oct-2023
$2
$0.92 (85.19%)
$4.5
2 years 5 months 9 days ago
(15-May-2024)
2/3 (66.67%)
$-26.08 (-92.88%)
449
Buy Since 22-Nov-2023
$3840
$3838.97 (372715.53%)
$21120
2 years 7 months 3 days ago
(21-Mar-2024)
0/2 (0%)
$2686.08 (232.78%)
What is CLDI (Calidi Biotherapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CLDI (Calidi Biotherapeutics)?
Which analyst has the current lower performing score on CLDI (Calidi Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on CLDI (Calidi Biotherapeutics)?
Which analyst is the currently most bullish on CLDI (Calidi Biotherapeutics)?
Which analyst is the currently most reserved on CLDI (Calidi Biotherapeutics)?
